Moreover, the cells and soluble factors participating in this response in liver are also similar to those in parenchymal injury to kidney, lung, or skin. Fibrosis occurs earliest in regions where ...

The diagnosis of nonalcoholic steatohepatitis requires histopathologic evaluation because the lesions of parenchymal injury and fibrosis cannot be detected by imaging studies or laboratory tests.

The morbidity and mortality of hepatic fibrosis caused by various etiologies are high worldwide, and the trend is increasing annually. At present, there is no effective method to cure hepatic fibrosis ...

Hepatocytes, a parenchymal cell type constituting the majority of liver cells, comprising about 60% of the overall cell count and around 80% of the volume of liver. Sinusoidal endothelial cells, ...

Primary liver cells from both genotypes of mice were isolated for in vitro experiments. Results TREM-2 was expressed on non-parenchymal hepatic cells and induced during liver injury in mice and man.

Lupus Pleurisy about a Case in the Pneumophthisiology Department of the Ignace Deen National Hospital of the Conakry ...

Recently rediscovered is Aspergillus bronchitis in those with cystic fibrosis (CF), bronchiectasis especially ... Tracheobronchial involvement is present in a subset of patients, and may rarely be ...

Researchers have been trying for decades to stop the cells that damage the lung in people with pulmonary fibrosis. Now a team of Columbia and UCSD researchers may have found a clever solution that ...

Nodular regenerative hyperplasia–like changes in hepatic parenchyma. Hepatic parenchymal distortion, atrophy, and fibrosis, with no features of cirrhosis. Dr. Sanjeeva P. Kalva: Given the ...

Sionna Therapeutics is eyeing a $156 million IPO as the cystic-fibrosis-focused biotech looks to take its lead candidate into phase 2. The Waltham, Massachusetts-based company already unveiled ...